Financhill
Back

Biomea Fusion Quote, Financials, Valuation and Earnings

Buy
72

BMEA
Biomea Fusion

Last Price:
12.22
Seasonality Move:
43.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Biomea Fusion Price Quote

$12.22
-0.02 (-4.38%)
(Updated: May 18, 2024 at 5:38 AM ET)

Biomea Fusion Key Stats

Buy
72
Biomea Fusion (BMEA) is a Buy

Day range:
$12.17 - $12.85
52-week range:
$8.13 - $43.69
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.25%

Volume:
537.2K
Avg. volume:
739.9K
1-year change:
-62.79%
Market cap:
$440M
Revenue:
$0
EPS:
$-3.57

How Much Does Biomea Fusion Make?

Data Unavailable

Is Biomea Fusion Growing As A Company?

Data Unavailable

Biomea Fusion Stock Price Performance

  • Did Biomea Fusion Stock Go Up Last Month?
    Biomea Fusion share price went up by 6.43% last month
  • Did BMEA's Share Price Rise Over The Last Year?
    BMEA share price fell by -62.79% over the past 1 year

What Is Biomea Fusion 52-Week High & Low?

Biomea Fusion Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Biomea Fusion?

  • How Much Debt Does Biomea Fusion Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Biomea Fusion Have?
    Cash and short term investments quarterly total is $144.9M
  • What Is Biomea Fusion’s Book Value Per Share?
    Book value per share is 3.77

Is Biomea Fusion Cash Flow Positive?

  • What Is BMEA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$104.6M
  • What Is Biomea Fusion’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $163.7M
  • What Is Biomea Fusion’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$499K

Biomea Fusion Return On Invested Capital

Data Unavailable

Biomea Fusion Earnings Date & Stock Price

Biomea Fusion Competitors

  • Who Are Biomea Fusion's Competitors?
    Below is a list of companies who compete with Biomea Fusion or are related in some way:
    • BioXcel Therapeutics Inc (BTAI)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Poseida Therapeutics Inc (PSTX)
    • Palatin Technologies Inc (PTN)
    • Cartesian Therapeutics Inc (RNAC)

Biomea Fusion Dividend Yield

Data Unavailable

Biomea Fusion Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -4.81%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 54.43
Upside from Last Price: 344.68%

Major Shareholders

  • How many BMEA shares are owned by institutional investors?
    49.5M BMEA shares are owned by institutional investors
  • How many BMEA shares are owned by insiders?
    1.1M BMEA shares are owned by insiders